SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193805-23-001480
Filing Date
2023-11-13
Accepted
2023-11-13 08:30:25
Documents
1
Group Members
DEERFIELD MANAGEMENT COMPANY, L.P.DEERFIELD MGMT, L.P.DEERFIELD PARTNERS, L.P.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G e619055_sc13g-prelude.htm SC 13G 104895
  Complete submission text file 0001193805-23-001480.txt   106349
Mailing Address 780 THIRD AVENUE 37TH FLOOR NEW YORK NY 10017
Business Address
Flynn James E (Filed by) CIK: 0001352546 (see all company filings)

Type: SC 13G

Mailing Address 200 POWDER MILL ROAD WILMINGTON DE 19803
Business Address 200 POWDER MILL ROAD WILMINGTON DE 19803 (302) 547-3768
Prelude Therapeutics Inc (Subject) CIK: 0001678660 (see all company filings)

IRS No.: 811384762 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91717 | Film No.: 231395403
SIC: 2834 Pharmaceutical Preparations